Summit Therapeutics PLC logo

Summit Therapeutics PLC

0
FRA:UVF1 (USA)  
€ 0.20 (0%) Feb 26
At Loss
P/B:
33.60
Market Cap:
€ 65.72M ($ 71.80M)
Enterprise V:
€ -352.11M ($ -384.69M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Summit Therapeutics PLC Valuation Measures